Skip to main content

Profound Medical Corp.

PROF
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001628808

No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Profound Medical Corp. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of PROF: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders57155−1
Shares16.3M276.0K16.1M−7.37K (0.0%)
Value$105.6M$1.79M$105.8M+$1.95M (+1.9%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Profound Medical Corp. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to PROF in Q2 2026
InstitutionSharesValue% of portfolio
Concurrent Investment Advisors, LLC21,657$144.0K0.00%
Invesco Ltd.15,454$102.8K0.00%
Dimensional Fund Advisors LP12,822$85.3K0.00%
Tower Research Capital LLC (TRC)1,584$10.5K0.00%

Sold out (5)

Institutions that held Profound Medical Corp. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of PROF in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Simplex Trading, LLC36,718$237.9K
Jane Street Group, LLC36,687$237.7K
Captrust Financial Advisors10,398$67.4K
Rachor Investment Advisory Services, LLC297$1.93K
Parallel Advisors, LLC30$194

Not filed for Q2 2026 yet (1)

Institutions that held Profound Medical Corp. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PROF in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Paragon Associates & Paragon Associates II Joint Venture276,001$1.79M